ASGE Annual GI Advanced Practice Provider Course (On-Demand) - Clinical Case-Based Learning (Day Two)

Video Transcription

Video Summary

The video transcript features discussions on various topics related to liver diseases and drug-induced liver injury (DILI). Key points include differentiating between direct and indirect forms of DILI, strategies for determining mixed patterns versus hepatocellular injury based on liver enzyme elevations, screening for portal hypertension in cirrhotic patients, potential liver injury from herbal supplements like turmeric and green tea, and considerations for patients with elevated AFP levels and suspected liver malignancy like HCC. Additionally, the distinction between primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC) is highlighted. The importance of utilizing resources like LiverTox for evaluating drug-induced liver injury is emphasized.

Meta Tag

Concept Drug-Induced Liver Injury

Concept Liver Enzyme Pattern

Concept Portal Hypertension

Concept Primary Sclerosing Cholangitis

Concept Primary Biliary Cholangitis

Keywords

liver diseases

drug-induced liver injury

DILI

hepatocellular injury

portal hypertension

LiverTox

Drug-Induced Liver Injury

Liver Enzyme Pattern

Portal Hypertension

Primary Sclerosing Cholangitis

Primary Biliary Cholangitis